Supplementary Table S6 from Development of an Anti-CD99 Antibody Enables Targeting of Diffuse Midline Glioma
Year: 2025
Type: supplementary-materials
Abstract: Animal survival benefits after receiving either intravenous (IV), intrathecal (IT), or IT followed by IV delivery of 10D1 treatment as a monotherapy and when combined with FFRT.
Authors: Ilango Balakrishnan, Krishna Madhavan, Angela Pierce, Joshua Michlin, Breauna Brunt, Senthilnath Lakshmanachetty, Dong Wang, John DeSisto, Zachary James Nuss, Nathan Davidson, Faye Walker, Ammu Suresh, Andrew Donson, Bridget Sanford, Kenneth L. Jones, Etienne P. Danis, Siddhartha S. Mitra, Adam L. Green, Nathan Dahl, Rajeev Vibhakar, Sujatha Venkataraman
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4413381241